Dotmatics helping scientists make better drugs in less time using AI
Dotmatics executives Kalim Saliba and Steve Tharp explain in a CBS News Boston feature how the company leverages artificial intelligence to transform pharmaceutical drug discovery by providing innovative solutions that accelerate and improve the efficiency of scientific research and development in the life sciences sector.
In a CBS News Boston feature, Dotmatics executives Kalim Saliba and Steve Tharp discuss the impact of artificial intelligence (AI) in advancing scientific research and development for pharmaceutical drug discovery. They explain how Dotmatics is utilizing AI to revolutionize the field, offering innovative solutions to complex challenges in the life sciences sector.
The feature highlights Dotmatics' work in AI and its pivotal role in shaping the future of scientific discovery, particularly in making drug development more efficient and effective.
Related
NBC Louisiana: How AI is Accelerating Drug Discovery
In an NBC Louisiana feature, Dotmatics’ VP Phil Mounteney explained how AI is revolutionizing drug discovery by significantly reducing development time from up to ten years to potentially half, enhancing efficiency in analyzing vast data sets while ensuring data privacy by keeping sensitive information secure and in-house.
The Future of AI in Drug Discovery
The Forbes article discusses how AI is revolutionizing drug discovery by accelerating R&D and improving decision-making, highlighting Dotmatics’ role in integrating data and applying AI to scientific workflows, while also connecting these advancements to broader innovations in sustainability and global problem-solving.
NBC News: How AI is Transforming Drug Discovery
In an NBC News segment, Alister Campbell, VP of Dotmatics, explains how the company leverages AI to analyze large datasets, predict effective drug compounds, and streamline fragmented data systems and manual workflows, thereby accelerating and improving the efficiency of drug discovery.
Scripps News America Tonight
Phil Mounteney, VP of Science and Technology at Dotmatics, explains in Scripps News America Tonight how Dotmatics Luma uses AI to transform scientific research and pharmaceutical drug discovery by accelerating innovation, lowering costs, and shortening time-to-market for modern laboratories.
Gray TV Washington DC: AI helping scientists make drug breakthroughs
The Gray TV Washington DC feature highlights how scientists, including Christian Olsen of Dotmatics, are leveraging AI and machine learning to accelerate drug discovery and expedite bringing new drugs to market.
Lab Manager: AI in the Lab for Faster, Smarter Drug Discovery
Dotmatics VP of Strategy Christian Olsen explains in a Lab Manager article how AI enhances laboratory workflows by improving data analysis and accelerating decision-making, thereby augmenting research processes and boosting efficiency and innovation in drug discovery without replacing physical experiments.